Dr. Friedhoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
123 E 37th St.
New York, NY 10016
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1981 - 1982
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1977 - 1978
New York University School of MedicineClass of 1977
Certifications & Licensure
NY State Medical License 1978 - 2025
NJ State Medical License 1982 - 2005- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study of SkQ1 as Treatment for Dry-eye Syndrome Start of enrollment: 2018 Dec 06
Publications & Presentations
PubMed
- 3 citationsA call for a global ‘bigger’ data approach to Alzheimer diseaseEric D. Perakslis, Henry Riordan, Lawrence Friedhoff, Azmi Nabulsi, Emilio Merlo Pich
Nature Reviews. Drug Discovery. 2019-05-01 - 9 citationsFunctional neurotoxicity evaluation of noribogaine using video-EEG in cynomolgus monkeys.Simon Authier, Michael V. Accardi, Dominique Paquette, Mylene Pouliot, Joseph C. Arezzo
Journal of Pharmacological and Toxicological Methods. 2016-09-01 - 12 citationsSwitching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.Paul Glue, Gavin Cape, Donna Tunnicliff, Michelle Marie Lockhart, Fred Lam
Journal of Clinical Pharmacology. 2016-08-01
Books/Book Chapters
Press Mentions
INmune Bio Doses First Alzheimer’s Disease Patient in XPro1595 StudyDecember 2nd, 2019
INmune Bio Inc. To Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference WebinarNovember 26th, 2019
Axovant to Present Patient Function and Independence Data Analyses from Phase 2b Study of Investigational Treatment Intepirdine in Alzheimer’s Disease at CTAD 2016December 5th, 2016- Join now to see all
Professional Memberships
- Fellow
Industry Relationships
- Head of Research and Development, Roivant Sciences, Inc.One of four original employees. Designer of the unique management structure which has proved to provide more efficient/effective FDA approvals.2014 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
